Review Article
Recent Advances in NSAIDs-Induced Enteropathy Therapeutics: New Options, New Challenges
Table 2
Clinical trials using capsule endoscopy about protective effect on NSAID-induced small intestinal injuries.
| Author (year) | Protective drug | NSAID | Period |
| Goldstein et al. [26] (2005) | Celecoxib | Naproxen | 2 weeks | Fujimori et al. [31] (2009) | Misoprostol | Diclofenac sodium | 2 weeks | Watanabe et al. [32] (2008) | Misoprostol | Aspirin (low dose) | 8 weeks | Niwa et al. [33] (2008) | Rebamipide | Diclofenac | 1 week |
Fujimori et al. [34] (2011) | Rebamipide | Diclofenac | 2 weeks | Mizukami et al. [35] (2011) | Rebamipide | Aspirin (low dose) | 4 weeks | Niwa et al. [36] (2009) | Geranylgeranylacetone | Diclofenac sodium | 1 week | Endo et al. [37] (2011) | Lactobacillus casei | Aspirin + omeprazole | 3 months |
|
|